2026 Independent Medical Education Request for Proposal supports ophthalmologists through scalable education to improve diabetic macular edema care and team coordination in rural and community settings.
Funder: Roche
Due Dates: November 22, 2026 (Full application) | December 18, 2026 (Decision notification by)
Funding Amounts: Up to $250,000 in support
Summary: Supports independent practice-improvement education to strengthen diabetic macular edema care and interprofessional coordination in rural and community settings lacking retinal subspecialists.
Key Information: Applicants must be U.S.-based, accredited CME/CE providers in good standing with a registered gFRS account.
Genentech’s Independent Medical Education team, part of the Roche Group, supports independent, certified education that improves healthcare professionals’ knowledge, competence, and performance. This opportunity focuses on diabetic macular edema (DME), particularly gaps in intravitreal injection training, screening, referral, and ongoing management in rural and community settings lacking retinal subspecialists.
The program seeks practice- and quality-improvement initiatives that build comprehensive and general ophthalmologists’ skills and strengthen interprofessional care coordination. Funded initiatives must provide broad, scalable educational value rather than localized operational consulting or practice-management support. Peer-to-peer resources may include webinars, toolkits, case studies, or accredited modules. Education must remain non-promotional and independent of commercial products, with the accredited provider retaining control over program design, content, execution, and site interactions.